Home>Research>1870TiP – Tazemetostat in combination with a PARP Inhibitor or checkpoint inhibitor in patients with solid tumors

US Oncology Research Publications

« Back to All Resources

Poster
Lung
Treatment

1870TiP – Tazemetostat in combination with a PARP Inhibitor or checkpoint inhibitor in patients with solid tumors